Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) Piotroski F-Score: 7 (As of Jun. 29, 2026) — 17% Above Median


IST:GENIL Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS IST:GENIL
86 GF Score
Price ₺9.32
GF Value ₺8.12
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Gen Ilac Veglik Urunlerinayi ve Ticaret AS Piotroski F-Score?

Gen Ilac Veglik Urunlerinayi ve Ticaret AS IST:GENIL -2.31% 86 Piotroski F-Score is 7 as of Jun. 29, 2026, which is 17% above its 10-year median of 6.00. GuruFocus rates IST:GENIL with a GF Score™ of 86/100 and a GF Value™ of ₺8.12 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 978 Drug Manufacturers companies, Gen Ilac Veglik Urunlerinayi ve Ticaret AS ranks better than 91.82% on this metric.

Good Sign:

Piotroski F-Score is 7, indicates a very healthy situation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Gen Ilac Veglik Urunlerinayi ve Ticaret AS has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

The historical rank and industry rank for Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Piotroski F-Score or its related term are showing as below:

IST:GENIL' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 6   Max: 7
Current: 7

During the past 8 years, the highest Piotroski F-Score of Gen Ilac Veglik Urunlerinayi ve Ticaret AS was 7. The lowest was 3. And the median was 6.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS  (IST:GENIL) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Gen Ilac Veglik Urunlerinayi ve Ticaret AS Piotroski F-Score Related Terms


Gen Ilac Veglik Urunlerinayi ve Ticaret AS Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Piotroski F-Score Chart

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial 5.00 7.00 5.00 4.00 6.00

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.00 6.00 7.00 6.00 7.00

IST:GENIL vs ZTS, UTHR, VTRS: Piotroski F-Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gen Ilac Veglik Urunlerinayi ve Ticaret AS Piotroski F-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Piotroski F-Score falls into.


IST:GENIL
86GF Score
Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS IST:GENIL
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was 77.793 + 215.771 + 150.565 + 375.136 = ₺819 Mil.
Cash Flow from Operations was 730.663 + 174.787 + 1257.583 + -587.369 = ₺1,576 Mil.
Revenue was 4289.02 + 5351.011 + 4822.917 + 6624.046 = ₺21,087 Mil.
Gross Profit was 893.731 + 1035.852 + 1082.056 + 1950.844 = ₺4,962 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(14201.51 + 16257.283 + 17281.652 + 19450.351 + 22309.55) / 5 = ₺17900.0692 Mil.
Total Assets at the begining of this year (Mar25) was ₺14,202 Mil.
Long-Term Debt & Capital Lease Obligation was ₺296 Mil.
Total Current Assets was ₺12,024 Mil.
Total Current Liabilities was ₺9,074 Mil.
Net Income was -245.061 + 148.989 + 54.59 + 418.539 = ₺377 Mil.

Revenue was 4260.743 + 5035.159 + 4800.794 + 5048.864 = ₺19,146 Mil.
Gross Profit was 804.073 + 983.758 + 887.821 + 1083.748 = ₺3,759 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(8867.289 + 9880.69 + 10164.994 + 16247.477 + 14201.51) / 5 = ₺11872.392 Mil.
Total Assets at the begining of last year (Mar24) was ₺8,867 Mil.
Long-Term Debt & Capital Lease Obligation was ₺402 Mil.
Total Current Assets was ₺6,804 Mil.
Total Current Liabilities was ₺4,928 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's current Net Income (TTM) was 819. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's current Cash Flow from Operations (TTM) was 1,576. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=819.265/14201.51
=0.05768858

ROA (Last Year)=Net Income/Total Assets (Mar24)
=377.057/8867.289
=0.04252224

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's return on assets of this year was 0.05768858. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's return on assets of last year was 0.04252224. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's current Net Income (TTM) was 819. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's current Cash Flow from Operations (TTM) was 1,576. ==> 1,576 > 819 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=295.544/17900.0692
=0.01651077

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=401.771/11872.392
=0.03384078

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's gearing of this year was 0.01651077. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's gearing of last year was 0.03384078. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=12024.496/9074.379
=1.32510401

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=6803.567/4928.203
=1.38053708

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's current ratio of this year was 1.32510401. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's current ratio of last year was 1.38053708. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's number of shares in issue this year was 4508.852. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's number of shares in issue last year was 4549.339. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=4962.483/21086.994
=0.23533383

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=3759.4/19145.56
=0.19635884

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's gross margin of this year was 0.23533383. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's gross margin of last year was 0.19635884. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=21086.994/14201.51
=1.48484168

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=19145.56/8867.289
=2.15912214

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's asset turnover of this year was 1.48484168. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's asset turnover of last year was 2.15912214. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+1+1+0+1+1+0
=7

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Gen Ilac Veglik Urunlerinayi ve Ticaret AS has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 7 mean?
Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) has a Piotroski F-Score of 7 as of Jun. 29, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Gen Ilac Veglik Urunlerinayi ve Ticaret AS and its competitors. This is 17% above median its historical median of 6.00. Over the past decade, Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Piotroski F-Score has ranged from 3.00 to 7.00. According to the industry distribution chart, Gen Ilac Veglik Urunlerinayi ve Ticaret AS ranks #80 out of 978 companies in the Drug Manufacturers industry, placing it in the top 8.2%.
Is Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Piotroski F-Score too high?
Gen Ilac Veglik Urunlerinayi ve Ticaret AS's current Piotroski F-Score of 7 is 17% above median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 7.00. The Drug Manufacturers industry median Piotroski F-Score is 5.00. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's value of 7 is 40% above this industry median. Based on the distribution chart, Gen Ilac Veglik Urunlerinayi ve Ticaret AS ranks #80 out of 978 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Gen Ilac Veglik Urunlerinayi ve Ticaret AS has a GF Score™ of 86/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Piotroski F-Score compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Gen Ilac Veglik Urunlerinayi ve Ticaret AS ranks #80 out of 978 companies for Piotroski F-Score. This places Gen Ilac Veglik Urunlerinayi ve Ticaret AS in the top 8% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's value of 7 is 40% above this benchmark. Historically, Gen Ilac Veglik Urunlerinayi ve Ticaret AS's own Piotroski F-Score has ranged from 3.00 to 7.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, Gen Ilac Veglik Urunlerinayi ve Ticaret AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Drug Manufacturers company?
The median Piotroski F-Score among Drug Manufacturers companies is 5.00, based on 978 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's current Piotroski F-Score of 7 is 40% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Gen Ilac Veglik Urunlerinayi ve Ticaret AS and its competitors. For the Drug Manufacturers industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's current Piotroski F-Score is 7, which is 17% above median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gen Ilac Veglik Urunlerinayi ve Ticaret AS stock overvalued right now?
Based on GuruFocus' analysis, Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) is currently considered Modestly Overvalued. The stock's GF Value™ is ₺8.12, compared to a current price of ₺9.32 — trading 14.8% above its estimated fair value. The current Piotroski F-Score is 7, which is 17% above median its 10-year median of 6.00 and 40% above the Drug Manufacturers industry median of 5.00. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's overall GF Score™ is 86/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL), the current Piotroski F-Score is 7 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) Overvalued in 2026?

Based on GuruFocus' analysis, Gen Ilac Veglik Urunlerinayi ve Ticaret AS stock appears to be overvalued. The current stock price of ₺9.32 is trading 14.8% above its estimated GF Value™ of ₺8.12. GuruFocus considers Gen Ilac Veglik Urunlerinayi ve Ticaret AS to be Modestly Overvalued.

Key valuation signals for IST:GENIL:

  • Piotroski F-Score: 7 (17% above median its 10-year median of 6.00)
  • GF Value™: ₺8.12 vs. price of ₺9.32 (14.8% above fair value)
  • GF Score™: 86/100 with 5 warning signs
  • Industry Position: 40% above the Drug Manufacturers median (#80 of 978)

No single metric tells the full story. See the IST:GENIL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Gen Ilac Veglik Urunlerinayi ve Ticaret AS Business Description

Address Mustafa Kemal Mahallesi 2119.Sk. No:3, Cankaya, Ankara, TUR, 06520
Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS is a specialty pharmaceuticals company in Turkey. Its locally manufactured products include Cajex, Contra-K, Epamor, Genkort, Ilopera, among others, while imported products include AvonexPEN, Plegridy, Tecfidera, Regen-D among others.
86GF Score

Get the complete analysis for IST:GENIL

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₺9.32
Price
₺8.12
GF Value